University of Patras
Μελέτη μηχανισμών γενετικής αστάθειας στον καρκίνο του παγκρέατος
Abstract
dc:descriptionBackground/Aim: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with dismal prognosis. KRAS mutation is found in 90% of PDAC patients. Genomic instability due to defects in cell-cycle regulation/mitosis or deficient DNA-damage repair is a major driver of PDAC progression with clinical relevance. Deregulation of licensing of DNA replication leads to DNA damage and genomic instability, predisposing cells to malignant transformation. While overexpression of DNA replication-licensing factors has been reported in several human cancer types, their role in PDAC remains largely unknown. We aimed here to examine the expression and prognostic significance of the DNA replication-licensing factors chromatin licensing and DNA replication factor 1 (CDT1), cell-division cycle 6 (CDC6), minichromosome maintenance complex component 7 (MCM7) and of the ubiquitin ligase regulator of CDT1, cullin 4A (CUL4A), in PDAC. Materials & Methods: Expression levels of CUL4, CDT1, CDC6 and MCM7 were evaluated by immunohistochemistry in 76 formalin-fixed paraffin-embedded specimens of PDAC patients in relation to DNA-damage response marker H2AX, clinicopathological parameters and survival and we conducted bioinformatics analysis of data from online available databases to corroborate our findings. We also used pancreatic adenocarcinoma cell lines to examine DNA replication factors’ expression in relation to KRAS. Results: CUL4A and DNA replication-licensing factors were overexpressed in patients with PDAC and expression of CDT1 positively correlated with H2AX. Expression of CUL4A and CDT1 positively correlated with lymph node metastasis. Importantly, elevated CUL4A expression was associated with reduced overall survival and was an independent indicator of poor prognosis on multivariate analysis. In KRAS overexpressing PDAC cells DNA replication factors’ expression was also upregulated compared to PDAC cells with normal KRAS levels. Conclusion: Our findings implicate CUL4A, CDT1, CDC6 and MCM7 in PDAC progression and identify CUL4A as an independent prognostic factor for this disease.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tavlas, Panagiotis
- Ταβλάς, Παναγιώτης
Subjects
dc:subject × 21- Αδενοκαρκίνωμα παγκρέατος
- Κυτταρικός κύκλος
- Αδειοδότηση της αντιγραφής του DNA
- Pancreatic ductal adenocarcinoma
- Cell cycle
- DNA-replication licensing
- CUL4A
- MCM7
- Cdc6
- Cdt1
- Histone H2AX
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μοριακή ιατρική
- Κλινική Ιατρική
- Χειρουργική
- Basic Medicine
- Medical and Health Sciences
- Molecular Medicine
- Clinical Medicine
- Surgery
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58550